Evaluation of the Optimal Technique for Determination of Renal Function of Critically Ill Patients

This study has been completed.
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
First received: June 30, 2005
Last updated: December 19, 2007
Last verified: December 2007

The purpose of this study is to evaluate the optimal technique for determination of the renal function of critically ill patients.

Condition Intervention
Renal Function
Critical Illness
Procedure: Measurement of inulin clearance

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Evaluation of the Optimal Technique for Determination of the Renal Function of Critically Ill Patients

Resource links provided by NLM:

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Comparison of the determination of the renal function by other means than the golden standard, inulin clearance

Estimated Enrollment: 50
Study Start Date: June 2004
Study Completion Date: October 2006

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Over 18 years old
  • Intensive care patient
  • Given informed consent
  • Arterial infusion
  • A bladder catheter

Exclusion Criteria:

  • Diurese < 400 mL/d
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00117390

University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Principal Investigator: Eric Hoste, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00117390     History of Changes
Other Study ID Numbers: 2004/101
Study First Received: June 30, 2005
Last Updated: December 19, 2007
Health Authority: Belgium: Federal Agency for Medicines and Health Products, FAMHP

Additional relevant MeSH terms:
Critical Illness
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on April 16, 2014